Awiqli FlexTouch 700 E/ml
Awiqli FlexTouch 700 E/ml is a medicine authorised by Swissmedic under authorisation number 69389. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 March 2024 and the authorisation is limited until 06 March 2029. ATC code A10AE places the medicine in the group Drugs used in diabetes.
| Authorisation number | 69389 |
|---|---|
| Name | Awiqli FlexTouch 700 E/ml |
| Full name | Awiqli FlexTouch 700 E/ml, Injektionslösung im Fertigpen |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AE |
| First authorisation | 07 March 2024 |
| Authorisation validity | 06 March 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Awiqli FlexTouch 700 E/ml, Injektionslösung im Fertigpen | B | 07 March 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 1 | ml | A10AE | 07.06.1. | B |
| 2 | 1 x 1 | ml | A10AE | 07.06.1. | B |
| 3 | 1 x 1,5 | ml | A10AE | 07.06.1. | B |
| 4 | 1 x 1,5 | ml | A10AE | 07.06.1. | B |
| 5 | 1 x 3 | ml | A10AE | 07.06.1. | B |
| 6 | 1 x 3 | ml | A10AE | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Awiqli FlexTouch 700 E/ml authorised in Switzerland?
Yes. Awiqli FlexTouch 700 E/ml is authorised by Swissmedic under authorisation number 69389, data as of 01 September 2026. The authorisation is limited until 06 March 2029.
Which dispensing category does Awiqli FlexTouch 700 E/ml have?
Awiqli FlexTouch 700 E/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Awiqli FlexTouch 700 E/ml?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.